Answer on Question #45578 – Math – Statistics and Probability
A pharmaceutical firm has developed a nasal spray containing interferon, which it believes will limit the transmission of the common cold within families. In the general population, 15.1 percent of all individuals will catch a rhinovirus- caused cold once another family member contracts such a cold. The interferon spray was tested on 180 people, one of whose family members subsequently contracted a rhinovirus-caused cold. Only 17 of the test subjects developed similar colds.
a) At a significance level of 0.05, should Farooq conclude that the new spray effectively reduces transmission of colds?
b) What should it conclude at ?
c) On the basis of these results, do you think Farooq should be allowed to market the new spray? Explain.
Solution
a) Null hypothesis: the new spray effectively reduces transmission of colds.
Since the P-value (0.98366) is greater than the significance level (0.05), we can accept the null hypothesis.
At a significance level of 0.05 Farooq should conclude that the new spray effectively reduces transmission of colds.
b) At a significance level of 0.02 Farooq also should conclude that the new spray effectively reduces transmission of colds, because the P-value (0.98366) is greater than the significance level (0.02).
c) On the basis of these results, I think Farooq should be allowed to market the new spray. Because the P-value is greater than any reasonable significance level.
www.AssignmentExpert.com